SecBot SecBot
6-K ·Filed Aug 12, 2026

SNN

SMITH & NEPHEW PLC
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001654954-26-007490
Notable filing: 6-K
Actionable Insight ▲ Bullish

Cevian's continued accumulation at a $12.8B market cap suggests it sees significant upside from operational improvements or a strategic sale. Traders should monitor for a potential 13D amendment detailing Cevian's specific demands, which could catalyze a re-rating. The stock may see increased volatility as the activist builds its position.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$29.84
T+0 close · Aug 12, 2026 · via day close
Latest settled
+7.27%
T+60 · $32.01
Vs SPY
+12.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 12 $29.84entry
  2. T+1 · 3mo ago +0.90%α +0.21% · $30.11
  3. T+5 · 3mo ago −1.78%α −1.33% · $29.31
  4. T+20 · 2mo ago −7.44%α −5.54% · $27.62
  5. T+60 · 12d ago +7.27%α +12.38% · $32.01
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Activist investor Cevian Capital increased its stake in Smith & Nephew to 14.21% from 14.01%, accumulating shares through its Master Fund and Co-Investment vehicle. This is a continuation of Cevian's existing activist campaign, signaling growing conviction and potential pressure for operational or strategic changes at the orthopedic device maker. The incremental accumulation, while not crossing a new threshold, reinforces the activist's presence and could increase the likelihood of a breakup, divestiture, or management shakeup.

Key Facts

  • Cevian Capital II GP Limited increased its aggregate holding in Smith & Nephew to 14.214414% from 14.010786%.
  • The increase was driven by a rise in the Cevian Capital II Master Fund L.P. stake to 13.014856% (from 12.815710%).
  • Cevian Capital II Co-Investment - Series P L.P. holds 1.199558% (up from 1.195075%).
  • The total number of voting rights held is 119,179,419 shares.
  • The notification date is August 11, 2026, for a threshold crossing on August 7, 2026.

Financial Impact

Cevian now controls 14.21% of SNN, representing approximately $1.8B of the $12.8B market cap.

ownershipvoting rights

Risk Factors

  • Cevian may not achieve its desired changes, leading to a prolonged and costly campaign.
  • The incremental increase is small (0.2%) and may not immediately force management action.
  • Smith & Nephew's underlying business fundamentals (recent revenue/earnings trends) could deteriorate, offsetting any activist premium.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-007490
Document: 0001654954-26-007490-index-headers.html0001654954-26-007490
Document: 0001654954-26-007490-index.html0001654954-26-007490
Document: 0001654954-26-007490.txt0001654954-26-007490

Track record

42 reports on SNN

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (11h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026